XML 84 R74.htm IDEA: XBRL DOCUMENT v3.24.3
Segments - Summary of Segment Profit (Detail) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Amounts Allocated To Segments [Abstract]          
Consolidated operating income (loss) [1] $ (51)   $ 344 $ (274) $ (323)
Amounts Not Allocated To Segments [Abstract]          
Amortization 146   145 444 471
Other asset impairments, restructuring and other items [1] (23)   57 931 276
Goodwill impairment 600 $ 400 0 1,000 700
Intangible assets impairments 28   47 169 289
Legal settlements and loss contingencies 450   314 638 1,009
Other Unallocated Amounts 64   112 254 394
Revenues 4,332   3,850 12,315 11,389
Gross profit 2,148   1,851 5,943 5,230
R&D expenses 240   253 751 726
S&M expenses 626   576 1,891 1,726
G&A expenses 298   268 859 870
Segment profit [1] (51)   344 (274) (323)
Financial expenses, net 272   280 763 808
Consolidated income (loss) before income taxes [1] (324)   64 (1,037) (1,131)
Europe [Member]          
Amounts Allocated To Segments [Abstract]          
Consolidated operating income (loss) 373   338 1,137 1,017
Amounts Not Allocated To Segments [Abstract]          
Revenues 1,265   1,146 3,749 3,493
Gross profit 698   648 2,113 1,943
R&D expenses 55   62 173 168
S&M expenses 203   184 605 565
G&A expenses 67   66 197 196
Other loss (income) 1     1 (2)
Segment profit 373   338 1,137 1,017
International Markets [Member]          
Amounts Allocated To Segments [Abstract]          
Consolidated operating income (loss) 109   117 299 356
Amounts Not Allocated To Segments [Abstract]          
Revenues 613   591 1,802 1,750
Gross profit 306   293 889 861
R&D expenses 27   30 85 81
S&M expenses 134   116 397 353
G&A expenses 36   33 109 105
Other loss (income)     (2) (1) (34)
Segment profit 109   117 299 356
United States [Member]          
Amounts Allocated To Segments [Abstract]          
Consolidated operating income (loss) 748   571 1,727 1,421
Amounts Not Allocated To Segments [Abstract]          
Revenues 2,225   1,896 6,060 5,465
Gross profit 1,265   1,060 3,291 2,866
R&D expenses 151   156 475 460
S&M expenses 259   243 789 700
G&A expenses 107   93 300 289
Other loss (income)     (2) (1) (3)
Segment profit 748   571 1,727 1,421
Segments and Other Activities [Member]          
Amounts Allocated To Segments [Abstract]          
Consolidated operating income (loss) 1,214   1,020 3,162 2,816
Amounts Not Allocated To Segments [Abstract]          
Segment profit 1,214   1,020 3,162 2,816
Other Segments [Member]          
Amounts Allocated To Segments [Abstract]          
Consolidated operating income (loss) (16)   (5) (1) 22
Amounts Not Allocated To Segments [Abstract]          
Segment profit (16)   (5) (1) 22
Corporate Segment [Member]          
Amounts Allocated To Segments [Abstract]          
Consolidated operating income (loss) 1,230   1,025 3,163 2,794
Amounts Not Allocated To Segments [Abstract]          
Segment profit $ 1,230   $ 1,025 $ 3,163 $ 2,794
[1] The data presented for the prior period have been revised to reflect a revision in the presentation of these items in the consolidated financial statements. For additional information see note 1c.